Market closed
Climb Bio/$CLYM
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Climb Bio
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.
Ticker
$CLYM
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
18
Website
Climb Bio Metrics
BasicAdvanced
$92M
-
-$1.53
-0.10
-
Price and volume
Market cap
$92M
Beta
-0.1
52-week high
$11.55
52-week low
$1.05
Average daily volume
183K
Financial strength
Current ratio
31.408
Quick ratio
30.833
Long term debt to equity
0.177
Total debt to equity
0.251
Management effectiveness
Return on assets (TTM)
-10.30%
Return on equity (TTM)
-46.26%
Valuation
Price to book
0.43
Price to tangible book (TTM)
0.43
Price to free cash flow (TTM)
-4.209
Growth
Earnings per share change (TTM)
17.90%
3-year earnings per share growth (CAGR)
-28.76%
What the Analysts think about Climb Bio
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Climb Bio stock.
Climb Bio Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Climb Bio News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Climb Bio stock?
Climb Bio (CLYM) has a market cap of $92M as of April 17, 2025.
What is the P/E ratio for Climb Bio stock?
The price to earnings (P/E) ratio for Climb Bio (CLYM) stock is 0 as of April 17, 2025.
Does Climb Bio stock pay dividends?
No, Climb Bio (CLYM) stock does not pay dividends to its shareholders as of April 17, 2025.
When is the next Climb Bio dividend payment date?
Climb Bio (CLYM) stock does not pay dividends to its shareholders.
What is the beta indicator for Climb Bio?
Climb Bio (CLYM) has a beta rating of -0.1. This means that it has an inverse relation to market volatility.